Tropisetron
As of the edition of 20 October 2026, Tropisetron is a small molecule: in active development; acts on HTR3A, HTR3B and HTR3C and 2 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Active, 2006
- Kind
- Small molecule
- Registered trials
- 15, 0 stopped early
- Disease areas
- Cancer; Mental health; Nervous system; Blood and lymph; Immune system; Digestive system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 3 | 2 | 1 | 0 |
| Phase 2 | 1 | 1 | 0 | 0 |
| Phase 3 | 5 | 4 | 1 | 0 |
| Phase 4 | 6 | 3 | 0 | 0 |
| All trials | 15 |